Skip to content

Source filing unavailable

Q3 2010 · —
Revenue—
Net Income-$4.14Mno prior Q3 2009 on fileN/M vs Q2 2010
EPS Diluted-$0.23no prior Q3 2009 on fileN/M vs Q2 2010
Operating Cash Flowderived-$2,237,000—
Free Cash Flowderived-$2,248,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR